ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 552 filers reported holding ASTRAZENECA PLC in Q4 2018. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $30,569,000 | -9.1% | 557,821 | -12.3% | 1.38% | +22.7% |
| Q2 2020 | $33,641,000 | +14.3% | 636,056 | -3.5% | 1.12% | -4.7% |
| Q1 2020 | $29,424,000 | -9.3% | 658,837 | +1.2% | 1.18% | +46.3% |
| Q4 2019 | $32,451,000 | +9.4% | 650,848 | -2.2% | 0.81% | +12.4% |
| Q3 2019 | $29,662,000 | -0.4% | 665,517 | -7.7% | 0.72% | +7.3% |
| Q2 2019 | $29,771,000 | +18.7% | 721,201 | +16.3% | 0.67% | +22.8% |
| Q1 2019 | $25,073,000 | +30.9% | 620,151 | +23.0% | 0.54% | +20.3% |
| Q4 2018 | $19,148,000 | -15.3% | 504,164 | -11.8% | 0.45% | +1.1% |
| Q3 2018 | $22,616,000 | +6.2% | 571,541 | -5.8% | 0.45% | +16.7% |
| Q2 2018 | $21,301,000 | +1.0% | 606,687 | +1.1% | 0.38% | +12.6% |
| Q1 2018 | $21,085,000 | +2.0% | 600,197 | +0.8% | 0.34% | +27.2% |
| Q4 2017 | $20,664,000 | +5.5% | 595,499 | +3.0% | 0.27% | +11.7% |
| Q3 2017 | $19,578,000 | +16.0% | 577,875 | +16.7% | 0.24% | +3.0% |
| Q2 2017 | $16,881,000 | -23.7% | 495,175 | -30.3% | 0.23% | -20.2% |
| Q1 2017 | $22,139,000 | -14.3% | 710,935 | -24.8% | 0.29% | -16.8% |
| Q4 2016 | $25,822,000 | -6.4% | 945,170 | +12.5% | 0.35% | -12.5% |
| Q3 2016 | $27,596,000 | +59.5% | 839,815 | +46.6% | 0.40% | +35.0% |
| Q2 2016 | $17,298,000 | -99.9% | 572,985 | +13.1% | 0.30% | +33.8% |
| Q1 2016 | $14,271,065,000 | +81332.6% | 506,785 | -1.8% | 0.22% | -18.1% |
| Q4 2015 | $17,525,000 | +12.3% | 516,215 | +5.2% | 0.27% | +12.9% |
| Q3 2015 | $15,608,000 | +59.9% | 490,535 | +220.1% | 0.24% | +77.8% |
| Q2 2015 | $9,764,000 | +173.0% | 153,255 | +193.2% | 0.14% | +200.0% |
| Q1 2015 | $3,576,000 | -23.5% | 52,265 | -21.3% | 0.04% | -19.6% |
| Q4 2014 | $4,676,000 | +1.5% | 66,440 | +3.0% | 0.06% | +9.8% |
| Q3 2014 | $4,606,000 | -3.9% | 64,475 | 0.0% | 0.05% | +6.2% |
| Q2 2014 | $4,791,000 | -13.6% | 64,475 | -24.5% | 0.05% | 0.0% |
| Q1 2014 | $5,544,000 | +9.3% | 85,450 | 0.0% | 0.05% | +9.1% |
| Q4 2013 | $5,073,000 | +13.8% | 85,450 | -0.5% | 0.04% | +4.8% |
| Q3 2013 | $4,458,000 | +9.8% | 85,850 | 0.0% | 0.04% | +20.0% |
| Q2 2013 | $4,061,000 | – | 85,850 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |